A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression
Clinical trial NCT03693508 · COMPLETED
Trial details
- NCT number
- NCT03693508
- Sponsor
- Fundacion SEIMC-GESIDA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-13
- Primary completion
- 2020-05-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.